Is this a fair comparison for the FDA? Yes, because in the current system you are guilty until you prove your own innocence to their standard of evidence, which tends to vary based on who you are. One could argue that the potential harm of unregulated supplements is clear and present, yet the FDA chooses not to act.
To whom shall we write our complaints about the unregulated aspects of the food and drugs which have the potential to cause massive harm (but which apparently don't because people on aggregate are not as helpless as they sometimes appear)?
To your second point, the site has a few "locked" areas that are described as containing potentially upsetting or confusing information, and the user is advised to consult his/her physician before looking at the results. There is also downloadable information available to physicians.
Reducing the scope of the product would inherently reduce the scope of the FDA involvement, not that that is in any way relevant to any point I made.
> To your second point, the site has a few "locked" areas that are described as containing potentially upsetting or confusing information, and the user is advised to consult his/her physician before looking at the results. There is also downloadable information available to physicians.
I don't see how that's relevant to anything I said. Particularly, its not relevant to either the second point in the first paragraph (which concerns 23andMe abandoning the regulatory clearance process) or the point of the second paragraph (which concerns 23andMe failing to provide studies supporting their claims about the accuracy of the reports).
If you take the raw data and download various utilities that match SNPs with the literature, the result is far more scary and misleading -- and it reveals just how thoughtful and reserved 23andme's approach is.
23andme provides ample links to evidence for every single result. The confidence metric is a function of the study size and reproducibility for the studies pertaining to each and every result. Most have very low confidence.
IMHO the only legitimate beef is with the underlying scientific assumption behind 23andme, which is that statistical genetics is both useful and accurate. I consider it more of a form of entertainment than a likely way of gathering actionable information.
Then no one should be surprised that they are in trouble with a regulatory agency responsible for holding participants in the market they are in to compliance standards.
AirBnB, Uber/Lyft, 23andMe previously (with then-current California regulation requiring tests of the type they provide to be physician-ordered) have all done this with varying degrees of success.
No, FDA interest in 23andMe is driven by: 1) The fact that 23andMe's product is within the clear scope of what FDA is tasked to regulate under the FD&C Act, and 2) The fact that, having initiated the process of seeking regulatory clearance for their product as required, 23andMe abandoned that process and continued marketing the product.
> Every single concern mentioned in that letter is clearly and obviously addressed by the site as part of its core functionality.
Really? The lack of studies supplied by 23andMe establishing the validity of their process in delivering the outputs it gives is "addressed by the site as part of its core functionality"? How?